No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
607 |
4. Check minimum number of eventsNone |
607 |
5. Include endpointsNone |
607 |
6. Filter based on genotype QC (FinnGen only) |
514 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Mantle cell lymphoma, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Non-Hodgkin lymphoma, all, including Hilmo
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 514 | 147 | 367 |
| Unadjusted period prevalence (%) | 0.14 | 0.05 | 0.17 |
| Median age at first event (years) | 68.62 | 66.60 | 69.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 533
- Matched controls
- 5330
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9246.0
307.7
452
*
A03FA01
ATC
metoclopramide; systemic, rectal
27.3
307.7
331
302
WW500
NOMESCO Finland
Blood transfusion
82.3
307.7
198
38
XW000
NOMESCO Finland
Bone marrow biopsy
83.9
307.7
267
63
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
307.7
530
*
JN4BD
NOMESCO Finland
Extensive body CT
31.7
304.4
226
121
H02AB02
ATC
dexamethasone; systemic
100.9
290.1
152
21
A04AA01
ATC
ondansetron; systemic, rectal
58.5
289.7
169
42
L03AA02
ATC
filgrastim; parenteral
4292.4
253.1
224
*
JN6AD
NOMESCO Finland
CT of torso and neck
129.3
252.8
128
13
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
244.1
215
*
M04AA01
ATC
allopurinol; systemic
15.5
236.5
341
548
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1720.1
233.6
210
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
23.1
227.8
188
123
L03AA13
ATC
pegfilgrastim; parenteral
1563.8
218.8
198
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
38.2
182.7
117
39
JN4AD
NOMESCO Finland
Body CT examination
15.5
182.7
189
182
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
89.8
181.5
96
13
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
163.1
148
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1026.4
160.3
149
*
ZX120
NOMESCO Finland
Intravenous
13.6
146.3
159
162
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
905.9
145.2
136
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
139.9
128
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.0
128.4
210
360
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
23.9
126.6
95
48
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
119.4
110
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
24.7
111.7
82
39
ZX112
NOMESCO Finland
Subcutaneous
67.5
108.7
60
10
D70.82
ICD-10 Finland
Drug-induced neutropenia
434.7
107.4
104
*
Z51.5
ICD-10 Finland
Palliative care
12.0
106.6
120
126
R50.9
ICD-10 Finland
Fever, unspecified
7.3
105.3
208
428
WZC00
NOMESCO Finland
Treatment plan or consultation
5.9
93.7
284
858
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
91.3
85
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.2
89.9
113
137
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
20.9
87.0
68
37
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
81.4
76
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
81.4
76
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
185.0
77.4
79
5
1XC02, ,
NOMESCO Finland
156.4
77.3
80
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
37.6
76.4
48
14
XX3DW
NOMESCO Finland
Time consuming IT work
10.0
73.9
92
109
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
73.7
69
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.7
73.5
72
60
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
72.6
68
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
101.4
72.2
78
9
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
71.5
67
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
71.5
67
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
762.1
69.7
67
*
H02AB06
ATC
prednisolone; systemic
5.2
67.3
391
1853
J05AB11
ATC
valaciclovir; oral
5.4
65.8
164
402
C61
ICD-10 Finland
Malignant neoplasm of prostate
366.2
65.0
64
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.8
62.2
77
90
J01MA12
ATC
levofloxacin; systemic
4.6
60.0
201
622
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
59.5
56
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
59.5
56
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
59.2
144
343
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
634.2
58.9
57
*
TGC00
NOMESCO Finland
Bronchial lavation
11.3
58.7
65
65
N02AA05
ATC
oxycodone; systemic
4.7
57.9
180
524
WF002
NOMESCO Finland
Radical radiotherapy
216.4
57.2
58
*
212
Kela drug reimbursment
Gout
11.4
56.5
62
61
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
51.9
49
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
183.5
48.8
50
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
48.7
46
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
112.6
47.7
51
5
390
Kela drug reimbursment
Ibrutinib
+∞
47.6
45
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
46.5
44
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
46.5
44
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.1
46.4
66
91
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
65.2
46.3
53
9
WZC30
NOMESCO Finland
Teaching
4.5
45.2
136
379
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.2
43.7
82
152
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
87.8
43.7
48
6
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
58.4
41.2
48
9
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
40.1
38
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.6
39.6
42
39
1512
Kela drug reimbursment
Ibrutinib
+∞
39.0
37
*
WW409
NOMESCO Finland
Other aferesis
+∞
39.0
37
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
39.0
37
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
39.0
37
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
38.8
90
202
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
393.5
37.5
37
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
393.5
37.5
37
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
37.0
356
2027
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
198.4
36.2
37
*
L01EL01
ATC
ibrutinib; oral
+∞
35.8
34
*
116
Kela drug reimbursment
Prostate cancer
+∞
34.8
33
*
JN4CD
NOMESCO Finland
Very extensive body CT
12.4
34.6
35
30
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.9
34.5
56
89
L01AA02
ATC
chlorambucil; oral
+∞
32.6
31
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
32.6
31
*
WW402
NOMESCO Finland
Leucoferesis
+∞
32.6
31
*
ZX108
NOMESCO Finland
Inhalation
46.6
32.3
39
9
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
117.0
31.0
33
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
30.5
29
*
A02BC02
ATC
pantoprazole; systemic
3.4
30.2
424
2845
D70.89
ICD-10 Finland
Neutropenic splenomegaly
53.3
29.7
35
7
WW200
NOMESCO Finland
Immunization
8.8
29.5
38
46
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
29.4
28
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
28.4
27
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
27.8
233
1177
H02AB07
ATC
prednisone; oral
3.4
27.7
118
409
B01AB10
ATC
tinzaparin; parenteral
4.1
27.2
83
229
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
26.3
94
290
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
26.3
25
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.7
26.1
43
69
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
98.4
25.9
28
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
98.4
25.9
28
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
52.8
25.5
30
6
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
25.2
24
*
130
Kela drug reimbursment
Malignant tumour
+∞
25.2
24
*
L02AE02
ATC
leuprorelin; implant, parenteral
73.6
25.0
28
*
J01MA14
ATC
moxifloxacin; systemic
3.8
25.0
85
253
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
25.0
66
163
R06AE07
ATC
cetirizine; oral
2.6
24.6
238
1274
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
23.5
65
166
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
23.3
158
707
D69.5
ICD-10 Finland
Secondary thrombocytopenia
+∞
23.1
22
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
22.8
72
203
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
22.0
21
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
22.0
21
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
22.0
21
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
22.0
21
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
22.0
110
416
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
229.0
21.8
22
*
A07AA02
ATC
nystatin; oral
4.3
21.6
59
149
L02BB03
ATC
bicalutamide; oral
+∞
21.0
20
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
80.1
20.8
23
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.7
20.7
40
75
1AA09, ,
NOMESCO Finland
+∞
19.9
19
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
19.9
19
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
41.8
19.7
24
6
L01XE27
ATC
[U] ibrutinib
+∞
18.9
18
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
103.7
18.7
20
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
18.2
59
169
HA1AA
NOMESCO Finland
X-ray mammography
7.0
18.0
28
42
ZX090
NOMESCO Finland
Other technic of radiotherapy
69.0
17.8
20
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
17.8
17
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
17.8
17
*
B72
ICPC
Hodgkin Lymphoma
+∞
17.8
17
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
17.6
31
53
Y77
ICPC
Malignant neoplasm prostate
185.9
17.6
18
*
EMB10
NOMESCO Finland
Tonsillectomy
6.3
17.0
29
48
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
16.8
16
*
EMA10
NOMESCO Finland
Biopsy of tonsil
175.3
16.6
17
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
175.3
16.6
17
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.6
16.1
31
58
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
15.7
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
15.7
15
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
15.7
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
15.7
15
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
15.7
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.7
15
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
20.0
15.7
23
12
TK800
NOMESCO Finland
Hemodialysis
6.5
15.6
26
42
J05AB01
ATC
aciclovir; systemic
2.4
15.6
132
643
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
164.6
15.6
16
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.2
15.4
23
33
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
24.2
15.2
21
9
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
15.2
40
98
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
46.4
15.1
18
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
14.8
366
2692
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.2
14.8
154
818
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
14.7
43
114
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
14.6
14
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
14.6
14
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
14.6
14
*
B02.9
ICD-10 Finland
Zoster without complication
3.2
14.5
63
217
ZXE00
NOMESCO Finland
One hour or less
2.1
14.3
217
1329
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
A79
ICPC
Malignancy NOS
143.5
13.5
14
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
13.5
274
1851
A41.8
ICD-10 Finland
Other specified sepsis
5.8
13.5
25
45
J01DB01
ATC
cefalexin; oral
2.4
13.4
437
3504
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.2
13.3
36
90
L57.0
ICD-10 Finland
Actinic keratosis
2.9
13.3
69
263
B01AB05
ATC
enoxaparin; parenteral
2.1
13.3
178
1036
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
13.2
140
744
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
13.1
80
332
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.8
13.0
24
43
115
Kela drug reimbursment
Breast cancer
+∞
12.5
12
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
12.5
12
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
12.5
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
133.0
12.5
13
*
ZXC50
NOMESCO Finland
Cryotherapy
5.3
12.3
25
49
EBA10
NOMESCO Finland
Operative extraction of tooth
2.9
12.2
63
239
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
12.0
142
785
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.0
11.9
35
93
TQW99
NOMESCO Finland
Other minor procedure on skin
4.0
11.9
35
93
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
47.8
11.9
14
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
15.1
11.9
19
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
11.7
216
1393
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
11.7
77
331
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
19.5
11.7
17
9
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
11.5
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.5
11
*
L01BC06
ATC
capecitabine; oral
+∞
11.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
UJF32
NOMESCO Finland
Coloscopy
2.0
11.5
153
882
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
11.4
176
1068
127
Kela drug reimbursment
Transplant complication
13.1
11.2
19
15
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.3
11.2
29
70
H02AB09
ATC
hydrocortisone; systemic
8.3
11.2
24
30
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.9
11.1
23
27
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.0
134
746
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.9
10.9
32
85
J35.1
ICD-10 Finland
Hypertrophy of tonsils
15.9
10.9
17
11
J01MA02
ATC
ciprofloxacin; systemic
1.9
10.9
226
1507
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.1
10.8
23
47
ZZR00
NOMESCO Finland
Flap of skin
28.7
10.8
14
5
R50.8
ICD-10 Finland
Other specified fever
22.0
10.7
15
7
C03CA01
ATC
furosemide; systemic
1.9
10.7
221
1470
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
10.5
28
69
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
10.5
23
30
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.6
10.5
20
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
10.5
173
1069
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
10.4
10
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
10.4
10
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
10.4
10
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
10.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.4
10
*
1CX01, ,
NOMESCO Finland
+∞
10.4
10
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
10.4
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
B03XA02
ATC
darbepoetin alfa; parenteral
7.7
10.3
23
31
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.4
10.2
20
38
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
10.0
190
1224
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
9.9
58
235
TGD00
NOMESCO Finland
Needle biopsy of lung
101.8
9.4
10
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
30.6
9.4
12
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
30.6
9.4
12
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
30.6
9.4
12
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
9.4
9
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
9.4
9
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
9.4
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.2
9.4
13
6
A05AA02
ATC
ursodeoxycholic acid; oral
10.9
9.3
17
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
9.3
169
1069
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
9.2
80
388
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.2
9.2
89
451
B01AB04
ATC
dalteparin; parenteral
3.5
9.2
32
96
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.7
9.1
21
46
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.2
9.0
35
113
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.2
8.9
19
24
N05CF01
ATC
zopiclone; oral
1.8
8.9
183
1201
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
8.8
70
327
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
50.8
8.7
10
*
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
50.8
8.7
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
8.7
50
201
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
16.6
8.6
13
8
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.4
8.5
31
96
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
91.5
8.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
91.5
8.4
9
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
8.4
105
586
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
8.4
8
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.4
8
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
8.4
8
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
8.4
8
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
8.4
8
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
+∞
8.4
8
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
8.4
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
8.4
8
*
Z2221
NOMESCO Finland
Medical doctor
1.9
8.2
134
815
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
14.8
8.2
13
9
SPAT1153
SPAT
Removal of sutures
1.8
8.2
169
1106
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
33.9
8.1
10
*
TPX15
NOMESCO Finland
Removal of vascular injection port
33.9
8.1
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.9
8.1
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
8.1
193
1314
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
10.3
8.1
15
15
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
8.0
28
84
TAB00
NOMESCO Finland
Lumbar puncture
3.2
8.0
32
105
Z3231
NOMESCO Finland
Registered nurse
1.8
8.0
140
871
J02AC01
ATC
fluconazole; systemic
1.8
8.0
153
978
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.5
8.0
19
43
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.9
467
4092
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
8.6
7.9
16
19
KCD02
NOMESCO Finland
Transurethral resection of bladder
15.3
7.7
12
8
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
15.3
7.7
12
8
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
45.7
7.7
9
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
25.4
7.6
10
*
XX1AD
NOMESCO Finland
Other CT-examination
81.2
7.4
8
*
YX9AW, ,
NOMESCO Finland
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
B74
ICPC
Malignant neoplasm blood other
+∞
7.3
7
*
R05
ICD-10 Finland
Cough
1.9
7.3
113
675
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.2
227
1655
CBA10
NOMESCO Finland
Biopsy of eyelid
20.3
7.2
10
5
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
8.1
7.1
15
19
J12.8
ICD-10 Finland
Other viral pneumonia
12.2
7.1
12
10
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.1
7.0
16
23
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
6.9
45
192
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.5
6.9
23
67
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.8
6.9
16
24
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.4
6.8
17
40
N03AX16
ATC
[U] pregabalin
1.8
6.7
115
706
J01CA04
ATC
amoxicillin; systemic
1.7
6.7
399
3382
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.0
6.6
15
22
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
6.5
40
166
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
70.7
6.4
7
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
70.7
6.4
7
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
70.7
6.4
7
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
6.4
25
81
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
6.4
41
174
UJF34
NOMESCO Finland
Left colonoscopy
18.3
6.3
9
5
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
6BA02, ,
NOMESCO Finland
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
3AA13, ,
NOMESCO Finland
+∞
6.3
6
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
6.3
6
*
9673/3-C77.3
ICD-O-3
Mantle cell lymphoma of lymph nodes of axilla or arm
+∞
6.3
6
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
R59
ICD-10 Finland
Enlarged lymph nodes
+∞
6.3
6
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
L01CB01
ATC
etoposide; systemic
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
6.3
6
*
9673/3-C16.9
ICD-O-3
Mantle cell lymphoma of stomach, NOS
+∞
6.3
6
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
6.3
6
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
27.0
6.2
8
*
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.2
96
571
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.8
6.2
13
17
WX402
NOMESCO Finland
General anaesthesia
1.8
6.1
96
573
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
6.1
27
94
J35.0
ICD-10 Finland
Chronic tonsillitis
4.2
6.1
16
39
G53.0
ICD-10 Finland
Postzoster neuralgia
12.7
6.1
10
8
R4110
NOMESCO Finland
Physiotherapy
1.7
6.0
136
902
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
387
475
27.09
307.65
10.1
1.9
247.50
240.51
u/l
0.42
378
446
183
50
55.21
307.28
2.1
1.2
—
—
—
0
0
143
61
31.67
206.61
4.4
5.2
396.80
143.70
iu/ml
—
15
10
94
14
81.31
175.11
2.7
2.1
—
—
—
0
0
113
42
33.87
170.17
2.6
2.2
3190.63
324.57
u/ml
—
8
7
213
281
11.96
164.67
5.4
1.9
8.49
11.34
g/l
9.07
202
262
120
102
14.89
122.81
2.3
1.4
—
—
—
0
0
119
103
14.59
120.38
2.2
1.4
—
—
—
0
0
83
39
25.02
113.61
1.7
1.6
—
—
—
0
0
97
67
17.48
111.17
2.4
1.5
—
—
—
0
0
65
17
43.41
107.19
4.0
1.7
0.42
0.80
e9/l
1.70
58
17
355
1214
6.76
104.07
6.8
2.5
341.53
366.15
umol/l
3.93
347
1042
80
57
16.34
89.68
1.3
1.3
145.91
164.02
au/ml
0.55
34
20
251
706
5.83
89.11
7.6
2.5
0.81
0.83
mmol/l
1.94
246
653
143
236
7.91
87.92
3.2
1.3
1.06
1.24
g/l
0.40
132
223
59
22
30.03
87.41
5.7
2.0
28.21
47.24
%
4.57
43
13
203
489
6.09
85.28
3.9
1.9
67.29
66.27
e9/l
0.14
165
369
88
85
12.20
82.00
1.7
1.3
—
—
—
0
0
91
95
11.35
80.39
1.8
1.3
—
—
—
0
0
218
633
5.14
72.28
6.7
5.1
1.10
1.02
mmol/l
3.09
213
578
410
1970
5.69
70.67
10.4
3.8
34.31
35.36
g/l
3.09
394
1818
443
2270
6.64
70.50
36.6
5.8
3.30
4.45
e9/l
17.68
419
1958
438
2224
6.44
70.45
21.7
3.9
10.05
12.91
umol/l
11.93
431
2104
56
32
19.44
69.74
2.9
1.7
—
—
—
0
0
433
2192
6.20
69.46
14.4
5.3
0.16
0.21
e9/l
10.56
403
1897
54
30
19.92
68.10
2.9
1.7
—
—
—
0
0
65
53
13.83
67.05
1.8
1.4
—
—
—
0
0
65
55
13.32
65.53
1.7
1.5
—
—
—
0
0
246
844
4.56
64.80
3.1
1.8
—
—
—
0
0
76
83
10.51
64.63
1.7
1.3
—
—
—
0
0
142
312
5.84
64.35
2.3
1.4
—
—
—
0
0
71
71
11.38
64.22
1.7
1.3
—
—
—
0
0
83
107
9.00
62.13
1.7
1.6
—
—
—
0
0
191
606
4.35
54.46
2.5
1.8
—
—
—
0
0
47
31
16.53
54.32
3.0
1.1
—
—
—
0
0
47
31
16.53
54.32
3.0
1.1
—
—
—
0
0
47
31
16.53
54.32
3.0
1.1
—
—
—
0
0
94
167
6.62
52.58
2.3
3.4
—
—
—
0
0
48
35
14.97
52.55
5.4
2.7
48.03
56.93
%
1.18
48
28
196
649
4.19
52.46
2.5
1.8
—
—
—
0
0
413
2313
4.49
50.13
13.9
6.1
1.21
1.21
mmol/l
0.15
357
1994
43
28
16.62
49.95
1.2
1.1
—
—
—
0
0
58
68
9.45
46.44
3.2
1.4
32.83
32.91
pg
0.04
58
68
375
2065
3.75
44.25
12.8
5.7
1.21
1.20
mmol/l
0.38
365
1880
297
1458
3.34
41.31
9.6
2.0
2.33
2.35
mmol/l
1.29
283
1257
46
8
62.71
39.98
4.0
1.5
1.41
1.38
%
—
46
8
130
383
4.17
39.77
2.6
1.6
64.75
66.48
g/l
1.49
125
350
61
92
7.36
39.50
1.6
1.5
—
—
—
0
0
52
66
8.62
39.00
1.3
1.1
342.22
256.45
u/ml
0.44
23
33
36
32
11.99
34.80
1.7
1.4
—
—
—
0
0
330
1879
2.99
32.79
25.4
10.5
0.01
0.00
e9/l
0.59
296
1542
179
742
3.13
31.57
2.5
1.3
1.89
2.90
g/l
7.58
145
432
87
229
4.35
30.50
3.4
1.5
20.31
2.82
ug/l
0.53
68
177
39
47
8.87
30.35
1.3
1.3
—
—
—
0
0
31
27
12.13
30.28
1.8
1.4
—
—
—
0
0
326
1917
2.80
29.21
6.0
2.5
—
—
estimate
—
0
0
31
30
10.91
28.25
1.8
1.4
—
—
—
0
0
36
11
34.97
28.14
1.3
1.5
—
—
—
0
0
457
3265
3.80
28.13
27.8
5.6
82.43
77.76
u/l
1.56
448
3032
199
938
2.79
27.09
6.9
2.1
2.45
2.44
mmol/l
0.79
189
818
34
40
9.01
26.91
1.9
1.4
—
—
—
0
0
36
46
8.32
26.70
1.1
1.1
—
—
—
0
0
124
463
3.19
25.60
7.6
2.2
7.38
7.75
umol/l
0.07
113
407
30
33
9.57
24.95
1.1
1.2
—
—
—
0
0
60
145
4.54
23.28
1.9
1.2
—
—
—
0
0
236
1301
2.46
22.35
4.0
3.0
0.27
0.48
e6/l
1.52
192
952
200
1023
2.53
22.27
6.0
2.2
—
—
—
0
0
261
1515
2.42
21.91
4.2
3.1
22.68
111.61
e6/l
1.21
214
1158
53
123
4.67
21.59
1.6
1.7
—
—
—
0
0
436
3223
2.94
21.30
8.0
4.2
15.98
12.40
mm/h
3.87
416
2962
201
1058
2.44
20.76
3.1
2.4
4.41
4.55
e6/l
0.04
184
960
347
2328
2.41
20.36
16.7
18.4
1.26
1.36
inr
2.71
301
1959
75
235
3.55
20.27
2.0
1.7
1.59
1.55
g/l
0.14
62
210
28
12
24.54
20.15
3.7
1.2
—
—
—
0
0
28
12
24.54
20.15
3.7
1.1
—
—
—
0
0
28
12
24.54
20.15
3.7
1.1
—
—
—
0
0
79
257
3.43
20.15
1.6
1.4
—
—
—
0
0
127
552
2.71
19.43
4.9
3.0
1.89
2.03
mmol/l
0.18
112
476
272
1672
2.28
19.23
5.1
3.7
85.79
119.23
e6/l
0.40
220
1189
92
339
3.07
19.07
10.0
3.5
1.23
1.22
mmol/l
0.97
87
283
29
17
17.96
18.91
3.7
1.1
—
—
—
0
0
29
17
17.96
18.91
3.7
1.1
—
—
—
0
0
29
17
17.96
18.91
3.7
1.1
—
—
—
0
0
29
17
17.96
18.91
3.7
1.1
—
—
—
0
0
24
9
27.83
17.96
3.9
1.2
27.16
22.59
u/l
—
24
9
390
2840
2.39
17.69
6.5
4.5
2.25
2496.77
e6/l
—
8
52
382
2772
2.33
17.23
9.4
4.7
6.54
6.85
mmol/l
3.07
375
2641
25
13
20.11
17.02
1.4
1.0
—
—
—
0
0
51
141
3.89
16.48
2.0
1.3
2.81
1.41
ratio
1.36
23
85
54
158
3.69
16.09
2.1
1.3
30.42
36.57
mg/l
0.58
43
136
53
158
3.61
15.35
2.1
1.3
56.72
50.46
mg/l
0.26
44
135
36
82
4.64
14.95
3.1
2.1
232.48
73.56
u/ml
0.32
31
65
135
676
2.34
14.89
3.0
2.6
25.77
23.11
%
0.78
129
627
26
45
6.02
14.59
3.2
2.3
—
—
—
0
0
54
169
3.44
14.52
2.9
1.3
0.76
0.24
g/l
0.74
45
150
141
728
2.27
14.43
3.0
2.6
2.06
2.23
g/l
3.27
133
669
40
107
3.96
13.51
2.6
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
157
3.41
13.37
2.8
2.4
0.45
0.37
iu/ml
0.62
29
90
204
1255
2.01
13.02
2.3
2.3
2.99
2.74
mg/l
0.92
178
1062
28
60
4.87
12.49
1.1
1.2
85.60
169.65
miu/ml
—
5
20
50
166
3.22
12.23
1.7
2.1
39.38
38.13
u/l
0.15
45
141
16
6
27.42
12.11
2.1
1.0
—
—
—
0
0
44
136
3.44
12.05
2.8
1.3
0.00
0.00
g/l
-0.00
39
124
76
321
2.60
11.98
2.4
1.6
—
—
—
0
0
21
18
12.09
11.91
1.2
1.1
—
—
—
0
0
312
2266
1.91
11.78
4.6
3.8
0.00
0.00
estimate
-0.00
88
467
144
810
2.07
11.55
3.6
2.8
1.01
1.03
e6/l
0.03
79
431
100
489
2.29
11.42
5.9
3.4
—
—
—
0
0
314
2304
1.88
11.28
4.7
3.8
0.00
0.00
estimate
-0.00
91
475
313
2310
1.86
10.88
4.8
3.8
0.00
0.01
estimate
0.65
87
446
132
744
2.03
10.41
3.8
3.0
1.11
1.52
e6/l
0.51
66
361
21
41
5.29
10.39
3.5
1.2
—
—
—
0
0
21
42
5.16
10.12
3.5
1.2
—
—
—
0
0
21
42
5.16
10.12
3.5
1.2
—
—
—
0
0
248
1737
1.80
9.91
3.6
3.3
1478.28
1637.25
ng/l
0.34
231
1507
17
14
12.50
9.91
3.0
1.2
—
—
—
0
0
17
14
12.50
9.91
3.0
1.2
—
—
—
0
0
81
384
2.31
9.88
2.0
1.7
393.54
366.95
nmol/l
0.57
76
348
209
1401
1.81
9.60
2.8
2.3
59.30
61.61
u/l
0.12
198
1299
18
18
10.31
9.58
1.7
1.6
—
—
—
0
0
18
18
10.31
9.58
2.9
1.2
—
—
—
0
0
18
18
10.31
9.58
2.9
1.2
—
—
—
0
0
18
18
10.31
9.58
1.7
1.6
—
—
—
0
0
9
0
+∞
9.40
1.8
0.0
—
—
—
0
0
33
100
3.45
9.32
1.3
1.3
240.17
305.98
ug/g
0.80
18
62
262
1895
1.75
9.14
3.8
3.0
376.79
145.60
ug/l
8.19
243
1745
21
46
4.71
9.13
3.6
1.2
—
—
—
0
0
21
46
4.71
9.13
3.6
1.2
—
—
—
0
0
21
46
4.71
9.13
3.6
1.2
—
—
—
0
0
66
300
2.37
8.84
4.9
3.6
2.09
2.22
mmol/l
0.11
61
219
32
99
3.37
8.76
1.4
1.3
—
—
—
0
0
278
2061
1.73
8.75
3.2
2.4
—
—
—
0
0
192
1291
1.76
8.50
5.0
3.8
0.00
0.01
estimate
0.50
78
425
73
355
2.22
8.35
4.9
3.7
4.94
5.20
kpa
2.33
73
340
13
9
14.76
8.24
1.2
1.2
—
—
—
0
0
13
9
14.76
8.24
1.1
1.0
—
—
—
0
0
34
114
3.12
8.19
1.5
1.1
—
—
—
0
0
34
114
3.12
8.19
1.5
1.1
—
—
—
0
0
145
927
1.78
7.49
2.1
1.6
2.51
1.40
mg/l
0.82
129
721
46
191
2.54
7.48
4.6
1.6
—
—
—
0
0
29
95
3.17
7.27
1.5
1.3
—
—
—
0
0
29
95
3.17
7.27
1.5
1.3
—
—
—
0
0
106
623
1.88
7.18
10.1
6.6
1.14
1.03
mmol/l
0.09
86
509
72
375
2.06
6.90
2.0
2.0
0.19
0.20
g/l
0.15
66
340
14
17
8.42
6.86
1.1
1.4
—
—
—
0
0
18
45
4.10
6.67
1.2
1.7
27.20
23.44
u/ml
—
5
9
192
1372
1.62
6.39
6.9
2.7
40.11
37.92
u/l
0.15
186
1287
15
23
6.68
6.37
2.1
6.6
—
34.17
—
0
6
13
16
8.30
6.36
3.0
2.1
19.72
3.98
nmol/l
0.43
13
16
70
372
2.02
6.34
3.0
2.1
35.92
35.90
u/l
0.00
53
296
37
153
2.52
6.09
1.5
1.2
—
—
—
0
0
14
21
6.81
6.07
5.4
1.4
—
—
—
0
0
229
1724
1.58
6.04
4.7
3.8
0.00
0.01
estimate
0.78
76
375
31
118
2.73
6.01
1.4
1.5
0.09
0.19
iu/ml
—
9
24
65
345
2.01
5.91
3.0
2.5
59.88
61.51
ml/min/173m2
0.13
26
145
40
176
2.38
5.78
2.7
1.5
—
—
—
0
0
54
272
2.10
5.65
4.0
2.8
25.29
25.23
mmol/l
0.06
54
264
463
4159
1.86
5.60
52.9
15.6
23.68
27.17
mg/l
2.11
448
3414
254
1988
1.53
5.47
4.6
4.3
31.98
92.63
ng/l
1.25
223
1568
16
43
3.81
5.40
1.3
1.2
—
—
—
0
0
17
48
3.63
5.36
1.6
1.3
42215.83
171495.23
e6/l
0.53
12
30
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
27
104
2.68
5.14
1.8
1.7
—
—
—
0
0
12
19
6.43
5.10
1.7
3.0
1276.42
1344.05
u/ml
0.03
12
19
27
109
2.56
4.70
1.1
1.7
—
—
—
0
0
64
366
1.85
4.68
4.0
2.7
116.92
131.29
g/l
4.05
64
357
75
453
1.76
4.58
1.4
1.4
—
—
—
0
0
17
54
3.22
4.52
1.3
2.0
90.55
89.58
%
0.41
17
54
143
1022
1.55
4.51
3.6
4.3
118.66
351.34
ng/l
2.70
127
879
21
78
2.76
4.30
1.2
1.3
—
—
—
0
0
239
1921
1.44
4.14
2.4
2.4
80.15
78.04
nmol/l
0.51
223
1677
16
52
3.14
4.11
3.1
4.2
—
—
—
0
0
21
80
2.69
4.11
1.1
1.1
—
4.06
—
0
10
14
42
3.40
4.07
1.1
1.1
—
1.16
—
0
5
55
314
1.84
4.05
11.4
8.2
24.41
24.13
mmol/l
0.28
55
307
159
1204
1.46
3.70
4.4
3.3
0.03
0.00
estimate
0.49
69
359
11
25
4.47
3.64
1.2
1.0
—
—
—
0
0
6
6
10.09
3.50
1.2
1.2
—
—
—
0
0
13
42
3.15
3.39
1.0
1.2
—
17.00
—
0
12
9
18
5.07
3.38
3.6
4.3
—
—
—
0
0
145
1853
0.70
3.27
2.2
2.0
1.39
1.32
mmol/l
0.51
116
1523
379
4143
0.71
3.20
6.4
7.4
39.92
40.44
mmol/mol
0.57
350
3846
7
11
6.43
3.19
3.3
1.2
144.71
76.45
nmol/l
—
7
11
13
41
3.22
3.07
2.5
1.6
2952.84
95.08
u/ml
0.45
13
41
13
41
3.22
3.07
1.3
1.6
—
475.00
—
0
6
8
16
5.06
3.06
1.0
1.0
753.50
1939.62
miu/ml
—
8
16
308
2676
1.36
3.00
4.2
3.2
66.42
51.10
u/l
1.49
290
2481
7
14
5.05
2.73
13.3
3.6
4.96
5.43
kpa
—
7
14
7
14
5.05
2.73
13.3
3.6
11.07
10.13
kpa
—
7
14
6
10
6.05
2.70
1.0
1.0
—
—
—
0
0
10
30
3.38
2.61
1.0
1.7
1.00
13249.64
u/l
—
5
7
9
25
3.64
2.58
1.2
1.0
—
—
—
0
0
43
265
1.68
2.50
1.3
1.3
657.90
271.39
u/ml
0.39
38
246
15
63
2.42
2.48
3.9
2.4
1.20
1.19
mmol/l
0.34
15
63
6
12
5.04
2.41
1.0
1.0
—
—
—
0
0
8
22
3.68
2.37
1.7
1.4
—
—
—
0
0
15
65
2.35
2.33
3.9
2.4
4.18
4.14
mmol/l
0.20
15
65
15
65
2.35
2.33
3.9
2.4
105.73
105.25
mmol/l
0.16
15
65
152
1839
0.76
2.20
4.3
4.2
24.48
8.11
mg/mmol
0.53
91
1201
23
122
1.93
2.19
4.3
3.1
7.14
7.40
mmol/l
0.24
23
117
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
402
4288
0.75
2.17
5.4
6.5
2.59
2.53
mmol/l
0.59
358
3938
9
30
3.03
2.15
1.0
1.0
—
—
—
0
0
435
4074
1.37
2.10
44.6
15.3
74.88
74.64
ml/min/173m2
0.09
422
3784
121
956
1.34
2.09
1.8
1.8
1359.75
1153.59
nmol/l
1.31
94
738
153
1838
0.76
2.08
3.4
3.4
6.39
7.87
mmol/l
5.52
128
1549
19
96
2.02
2.08
2.2
2.4
254.37
195.04
%
1.34
19
89
7
20
3.53
2.06
1.0
1.1
—
—
—
0
0
7
20
3.53
2.06
3.9
2.2
0.86
1.05
index
—
7
20
466
4422
1.43
2.00
49.7
19.9
139.28
139.76
mmol/l
3.62
461
4337
7
21
3.36
1.97
2.7
1.6
0.22
0.26
nmol/l
—
7
14
390
4159
0.77
1.92
4.6
5.5
1.32
1.40
mmol/l
3.61
350
3808
466
4430
1.41
1.90
50.4
20.0
4.03
4.02
mmol/l
0.16
461
4339
6
17
3.56
1.84
1.0
1.3
—
—
—
0
0
182
1548
1.27
1.80
2.0
1.7
18.48
19.97
nmol/l
0.76
168
1297
395
4195
0.77
1.78
4.8
5.6
4.40
4.39
mmol/l
0.08
360
3867
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
5
13
3.87
1.72
1.0
1.1
—
15.42
—
0
6
74
562
1.37
1.66
13.4
7.4
—
—
—
0
0
105
845
1.30
1.60
1.2
1.3
0.90
1.54
u/ml
0.90
23
230
50
357
1.44
1.59
4.3
4.0
92.83
98.46
ng/l
0.13
39
308
8
33
2.45
1.54
1.3
1.2
9.87
10.61
u/l
—
8
28
22
136
1.64
1.34
2.4
2.4
115.45
133.39
g/l
4.55
22
112
43
583
0.71
1.31
4.7
5.5
31.66
31.97
%
0.07
35
374
25
161
1.58
1.31
1.0
1.0
—
—
—
0
0
378
3991
0.82
1.29
4.2
4.7
1.32
1.28
mmol/l
0.36
340
3623
254
2307
1.19
1.24
2.2
2.2
91.36
94.40
pmol/l
0.47
155
1212
13
71
1.85
1.20
4.4
1.6
15.74
28.61
u/ml
0.48
13
71
19
117
1.65
1.19
3.9
3.2
2.82
1.68
index
0.53
11
63
6
26
2.32
1.19
1.3
1.4
262.50
260.10
mu/l
—
6
21
130
1115
1.22
1.16
1.7
1.8
474.22
27223254.65
pmol/l
0.97
109
911
67
533
1.29
1.14
1.9
2.6
6.50
7.58
ug/l
0.20
61
471
27
184
1.49
1.13
1.1
1.2
58.57
126.94
u/ml
—
9
67
467
4511
1.28
1.12
58.2
21.0
89.27
85.24
umol/l
0.98
462
4450
7
32
2.20
1.08
1.0
1.2
138.29
98.59
pmol/l
—
7
32
7
34
2.07
1.03
1.4
1.2
90.57
37.30
u/l
—
7
27
14
220
0.63
0.94
1.6
1.9
3.19
3.44
mmol/l
—
9
175
336
3170
1.16
0.92
4.4
3.8
15.03
14.96
pmol/l
0.17
311
2842
11
63
1.76
0.90
1.6
1.4
—
—
—
0
0
176
1592
1.16
0.84
2.3
2.2
153.22
295.53
u/l
1.88
169
1492
53
650
0.80
0.84
1.4
1.3
27.56
11.36
u/ml
0.41
24
230
8
48
1.68
0.79
4.8
1.8
1511.50
1205.40
mg
—
8
48
119
1053
1.17
0.76
5.3
4.1
1.02
1.02
kg/l
1.01
81
699
16
109
1.48
0.71
1.3
1.2
—
—
—
0
0
7
40
1.76
0.71
1.1
1.1
—
295.00
—
0
6
467
4560
1.19
0.66
70.0
23.4
194.56
236.04
e9/l
30.96
461
4450
467
4562
1.19
0.65
71.1
23.9
36.86
40.54
%
38.27
462
4494
467
4562
1.19
0.65
69.9
23.4
4.05
4.49
e12/l
43.81
459
4430
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
5
86
0.58
0.56
1.2
1.3
1.39
1.48
g/l
—
5
86
9
60
1.51
0.54
1.3
1.4
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
382
3920
0.91
0.42
5.6
4.8
2.14
2.00
mu/l
1.05
357
3554
6
93
0.64
0.42
1.8
1.3
0.94
0.91
g/l
—
6
93
5
33
1.52
0.41
1.2
1.8
19.40
15.61
umol/l
—
5
28
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
226.89
—
0
18
413
4214
0.91
0.37
5.5
5.6
5.92
6.13
mmol/l
3.54
377
3816
14
108
1.30
0.35
2.6
2.9
35.57
37.11
umol/l
0.10
14
96
22
181
1.22
0.35
1.5
1.9
—
—
—
0
0
65
709
0.91
0.29
1.5
1.3
29.30
39.28
iu/ml
0.49
20
203
189
1967
0.94
0.27
5.2
4.0
21.17
24.07
%
2.38
106
948
11
138
0.79
0.26
1.2
1.3
—
—
—
0
0
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
7.5
—
10.35
—
0
11
8
101
0.79
0.21
1.9
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
6.6
—
5.94
—
0
13
32
292
1.10
0.16
2.0
1.4
—
—
—
0
0
145
1402
1.05
0.16
3.3
2.9
0.74
0.74
ug/l
0.01
101
954
15
130
1.16
0.16
2.7
3.3
0.86
0.83
nmol/l
—
8
106
18
159
1.14
0.15
1.6
1.9
—
—
—
0
0
5
47
1.06
0.09
1.2
1.2
—
70.29
—
0
7
5
61
0.82
0.08
1.0
1.4
—
—
—
0
0
5
63
0.79
0.08
1.2
1.1
—
11.50
—
0
10
7
66
1.06
0.08
1.3
2.2
—
—
—
0
0
241
2432
0.98
0.05
5.7
4.3
3.13
2.04
ug/l
0.60
218
2179
18
170
1.06
0.04
2.3
2.1
45.83
43.00
nmol/l
0.21
18
161
46
450
1.02
0.02
1.8
1.8
1.68
1.60
%
0.21
40
380
37
363
1.02
0.01
1.5
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
8.30
—
0
7
6
63
0.95
-0.00
1.0
1.0
1.65
1.55
g/l
—
6
56
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.19
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
25.98
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
1.2
1.3
0.62
28.98
nmol/l
—
6
60
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MANTLE_CELL_LYMPHOMA_WIDE – Mantle cell lymphoma, including Hilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).